Clinical Validation of a Novel Biomarker for the Prediction of Bone Metastasis in Early Stage Breast and Prostate Cancer

Project Information

OSTEOMET

Grant agreement ID: 719912

DOI 10.3030/719912

Project closed

EC signature date 25 February 2016

Start date 1 March 2016

End date 31 August 2016

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 71 429,00

EU contribution € 50 000,00

Coordinated by

Inbiomotion S.L
Spain